|Study Description:||The goal of this clinical research study is to learn the highest tolerable dose |
of ipilimumab that can be given to patients with uveal melanoma. Researchers
also want to learn if ipilimumab can help to control the disease.
Ipilimumab is designed to increase the immune system's ability to fight cancer.